Clinical potential of mass spectrometry-based proteogenomics

Clinical potential of mass spectrometry-based proteogenomicsClinical potential of mass spectrometry-based proteogenomics, Published online: 28 November 2018; doi:10.1038/s41571-018-0135-7Precision medicine approaches to the treatment of cancer are largely reliant on genomic analysis alone. In this Perspective the authors provide a rationale for the incorporation of analysis of the proteome, which is a rich source of biological heterogeneity, into the treatment and management of patients with cancer.

Source: Nature Clinical Practice Oncology - November 28, 2018 Category: Cancer & Oncology Authors: Bing Zhang Jeffrey R. Whiteaker Andrew N. Hoofnagle Geoffrey S. Baird Karin D. Rodland Amanda G. Paulovich Source Type: research